Reference 2017-513

REF:            2017-513

Subject:        Intra-vitreal injections/implants

    

 

Request:

Within your trust how many intra-vitreal injections/implants have been used in the latest 4 months, if possible between May and August 2017?

If your trust is able to identify injections/implants by eye conditions please split by the drug used [ranibizumab, bevacizumab, aflibercept, Fluocinolone and Dexamethasone].

  Lucentis (ranibizumab) Injections Avastin (bevacizumab) Injections Eylea (aflibercept) Injections Illuvien (Fluocinolone) Impants Ozudex (Dexamethasone) Implants
Total          
Wet Age Related Macular Degeneration (wAMD)          
Diabetic Macular Oedema (DMO)          
Retinal Vein Occlusion – Central or Branch (CRVO or BRVO)          
Other eg mCNV          

 

Response:

Please find information attached.

2017-513 FOI Request intra-vitreal injections implants [13 kb] Ms Excel

 

Visitor restrictions

To protect you and our staff during the current outbreak of Covid-19 we’ve put in place significant restrictions on hospital visitors.

Full details of these can be found on our website.

We would like to thank you for your understanding and helping us stop the spread of Covid-19.

Read More

Stay Home. Protect the NHS. Save Lives.

Close